Potassium Intake-response Trial to Control Hypertension (PITCH)
Sponsor: National Institute of General Medical Sciences (NIGMS)
Terminated
The Principal Investigator moved to a new institution and funding for the study was discontinued.
Other terminated trials from National Institute of General Medical Sciences (NIGMS)
- Childhood Obesity · Phase NA · Apr 2025
- Peripheral Arterial Disease · Phase NA · Mar 2025
- Aneurysmal Subarachnoid Hemorrhage · Phase PHASE3 · Oct 2023
- Opioid-use Disorder · Phase NA · Aug 2023
- Vitamin K Status · Phase NA · Jul 2023
See all terminations from National Institute of General Medical Sciences (NIGMS)
Other Blood Pressure trials with similar outcome
Listed as NCT05758142, this NA trial focuses on Blood Pressure and remains terminated or withdrawn. Sponsored by National Institute of General Medical Sciences (NIGMS), it has been updated 7 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Feb 2024 — Jun 2024 [monthly]
Recruiting NA
-
Jun 2023 — Feb 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
May 2023 — Jun 2023 [monthly]
Recruiting NA
-
Apr 2023 — May 2023 [monthly]
Recruiting NA
First recorded
Mar 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of General Medical Sciences (NIGMS)
- Tulane University
For direct contact, visit the study record on ClinicalTrials.gov .